Synovus Financial Corp Boston Scientific Corp Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Synovus Financial Corp holds 17,518 shares of BSX stock, worth $1.59 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,518

Previous 17,518 -0.0%

Holding current value

$1.59 Million

Previous $1.47 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $85,144 - $98,028	1,167 Added 7.14%	17,518 $1.47 Million
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $2,356 - $2,719	-35 Reduced 0.21%	16,351 $1.26 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $10,713 - $12,763	186 Added 1.15%	16,386 $1.12 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $513,242 - $559,157	10,226 Added 171.18%	16,200 $855,000
Q2 2023 Aug 08, 2023	BUY	$49.72 - $54.64 $1,591 - $1,748	32 Added 0.54%	5,974 $323,000
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $1,713 - $1,901	-38 Reduced 0.64%	5,942 $297,000
Q4 2022 Feb 06, 2023	BUY	$39.56 - $47.22 $553 - $661	14 Added 0.23%	5,980 $276,000
Q3 2022 Oct 27, 2022	BUY	$36.71 - $109.66 $7,855 - $23,467	214 Added 3.72%	5,966 $230,000
Q2 2022 Aug 10, 2022	BUY	$35.24 - $47.1 $202,700 - $270,919	5,752 New	5,752 $215,000
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $235,256 - $259,415	-5,752 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$38.58 - $44.24 $20,177 - $23,137	-523 Reduced 8.33%	5,752 $245,000
Q1 2021 May 11, 2021	SELL	$35.27 - $39.67 $129,335 - $145,469	-3,667 Reduced 36.88%	6,275 $242,000
Q4 2020 Feb 11, 2021	SELL	$33.15 - $41.97 $6,630 - $8,394	-200 Reduced 1.97%	9,942 $357,000
Q3 2020 Nov 09, 2020	SELL	$34.44 - $42.23 $5,510 - $6,756	-160 Reduced 1.55%	10,142 $387,000
Q2 2020 Aug 10, 2020	SELL	$30.19 - $39.11 $225,126 - $291,643	-7,457 Reduced 41.99%	10,302 $362,000
Q1 2020 Apr 24, 2020	BUY	$25.83 - $45.71 $198,891 - $351,967	7,700 Added 76.55%	17,759 $581,000
Q4 2019 Feb 06, 2020	BUY	$37.87 - $45.37 $12,913 - $15,471	341 Added 3.51%	10,059 $455,000
Q3 2019 Nov 01, 2019	BUY	$40.31 - $43.45 $59,900 - $64,566	1,486 Added 18.05%	9,718 $394,000
Q2 2019 Aug 08, 2019	BUY	$34.91 - $42.98 $82,422 - $101,475	2,361 Added 40.21%	8,232 $354,000
Q4 2018 Feb 07, 2019	BUY	$31.73 - $39.04 $27,636 - $34,003	871 Added 17.42%	5,871 $207,000
Q3 2018 Nov 01, 2018	BUY	$32.83 - $38.63 $44,517 - $52,382	1,356 Added 37.21%	5,000 $191,000
Q2 2018 Aug 01, 2018	BUY	$26.84 - $34.32 $1,073 - $1,372	40 Added 1.11%	3,644 $120,000
Q1 2018 May 07, 2018	BUY	$25.2 - $28.54 $90,820 - $102,858	3,604 New	3,604 $99,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Boston Scientific Corp Transaction History